Sunshine Biopharma Shares Volatile After $6M Deal, 50-Cent Mark in Focus

Sunshine Biopharma Inc. stock swung sharply on Monday. The Fort Lauderdale drugmaker set a $6 million public deal at 50 cents a unit. Shares on Nasdaq jumped above the offering price but couldn’t hold those gains, dropping back toward 50 cents as trading stayed busy.